Hypothalamic superoxide dismutase, xanthine oxidase, nitric oxide, and malondialdehyde in rats fed with fish ω-3 fatty acids

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 4, 2004, Pages 693-698

  Songur, Ahmet ^a   Sarsilmaz, Mustafa ^b   Sogut, Sadik ^c   Ozyurt, Birsen ^d   Ozyurt, Huseyin ^d   Zararsiz, Ismail ^b   Turkoglu, Asli Ozdem ^b  

^a AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c MUSTAFA KEMAL UNIVERSITY   (Turkey)

^d GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

ACTH; adrenocorticosteroid hormone; central nervous system; CNS; DHA; docosahexaenoic acid; EFA; eicosapentaenoic acid; EPA; essential fatty acid; Hypothalamus; Malondialdehyde; Nitric oxide; Omega 3 essential fatty acids; Superoxide dismutase; Xanthine oxidase

Indexed keywords

ANTIOXIDANT; ETHER; MALONALDEHYDE; MARINCAP CAPSULE; NITRIC OXIDE; OMEGA 3 FATTY ACID; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECAPITATION; DIET; ENZYME ACTIVITY; FEEDING; FISH; HYPOTHALAMUS; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; RAT; TISSUE LEVEL;

ANIMALS; DIET; FATTY ACIDS, OMEGA-3; HYPOTHALAMUS; MALE; MALONDIALDEHYDE; NERVE TISSUE PROTEINS; NITRIC OXIDE; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ULTRAVIOLET; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 3342913098     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.05.006     Document Type: Article

References (37)

1. Akyol O. Increased lipid peroxidation in schizophrenia: a marker of membrane breakdown. Eur. Psychiatr. 17(Suppl. 1):2002;75S
2. Akyol O., Herken H., Uz E., Fadillioglu E., Unal S., Sogut S., Ozyurt H., Savas H.A. The indices of endogenous oxidative and antioxidative precesses in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 26:2002;995-1005
3. Altamura A.C., Boin F., Maes M. HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. Eur. Neuropsychopharmacol. 10:1999;1-4
4. Arivazhagan P., Thilakavathy T., Ramanathan K., Kumaran S., Panneerselvam C. Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and protein oxidation in various brain region of aged rats. J. Nutr. Biochem. 13:2002;619-624
5. Beauclair L., Vinogradov S., Riney S.J., Csernansky J.G., Hollister L.E. An adjunctive role for ascorbic acid in the treatment of schizophrenia? J. Clin. Psychopharmacol. 7:1987;282-283
6. Cortas N.K., Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36:1990;1440-1443
7. Cotter D.R., Pariante C.M., Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 55:2001;585-595
8. Das M., Mukhtar H., Seth P.K. Aryl hydrocarbon hydroxylase and glutathione-S-transferase activities in discrete regions of rat brain. Arch. Biochem. Biophys. 217:1982;205-215
9. Evans P.H. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49:1993;577-587
10. Garver D.L. Neuroendocrine findings in the schizophrenias. Neurol. Clin. 6:1988;103-109
11. Glen A.I.M., Glen E.M.T., Horrobin D.F., Vassadi K.S., Spellman M., Morse-Fisher N., Ells K., Shinner F.S. A red cell membrane abnormalities in a subgroup of schizophrenic patients: evidence of two diseases. Schizophr. Res. 12:1994;53-61
12. Herken H., Uz E., Ozyurt H., Sogut S., Virit O., Akyol O. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol. Psychiatry. 6:2001;66-73
13. Horrobin D.F., Manku M.S., Morse-Fisher N., Vaddadi K.S., Courtney P., Glen A.I.M., Glen E., Spellman M., Bates C. Essential fatty acids in human plasma phospholipids in schizophrenics. Biol. Psychiatry. 25:1989;562-568
14. Horrobin D.F., Manku M.S., Hillman S., Iain A., Glen M. Fatty acid levels in brains of schizophrenics and normal controls. Biol. Psychiatry. 30:1991;795-805
15. Jaber M., Robinson S.W., Missale C., Caron M.G. Dopamine receptors and brain function. Neuropharmacology. 35:1996;1503-1519
16. Kanemitsu H., Nakagomi T., Tamura A., Tsuchiya T., Kono G., Sano K. Differences in the extent of primary ischemic damage between middle cerebral artery coagulation and intraluminal occlusion models. J. Cereb. Blood Flow Metab. 22:2002;1196-1204
17. Keshevan M.S., Mallinger A.G., Pettegrew J.W., Dippold C. Erythroctye membrane phospholipids in psychotic patients. Psychiatry Res. 49:1993;89-95
18. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275
19. Mahadik S.P., Scheffer R.E. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot. Essent. Fat. Acids. 55:1996;45-54
20. Marteinsdottir I., Horrobin D.F., Stenfors C., Theodorsson E., Mathe A.A. Changes in dietary fatty acids alter phospholipid fatty acid composition in selected regions of rat brain. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 22:1998;1007-1021
21. Marx C.E., Lieberman J.A. Psychoneuroendocrinology of schizophrenia. Psychiatr. Clin. North Am. 21:1998;413-434
22. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol. Psychiatry. 51:2002;775-787
23. Newman R.E., Storlien L.H., Bryden W.L., Kirby A.C., Downing J.A. Dietary n-3 and n-6 fatty acids alter avian pituitary sensitivity. Nutr. Neurosci. 6:2003;343-350
24. Oury T.D., Card J.P., Klann E. Localization of extracellular superoxide dismutase in adult mouse brain. Brain Res. 850:1999;96-103
25. Peet M., Laugharne J., Rangarajan N., Horrobin D.F., Reynolds G. Depleted red cell membrane essential fatty acids in drug treated schizophrenic patients. Psychiatry Res. 29:1995;227-232
26. Prajda N., Weber G. Malign transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett. 59:1975;245-249
27. Sahin S., Sogut S., Ozyurt H., Uz E., Ilhan A., Akyol O. Tissue xanhine oxidase activity and nitric oxide level after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci. Res. Commun. 31:2002;111-121
28. Sarsilmaz M., Songur A., Kus I., Ozyurt B., Gulec M., Sogut S., Ilhan A., Akyol O. The regulatory role of dietary omega-3 essential fatty acids on oxidant/antioxidant balance in rat hippocampus. Neurosci. Res. Commun. 33:2003;114-123
29. Sarsilmaz M., Songur A., Ozyurt H., Kus I., Ozen O.A., Ozyurt B., Sogut S., Akyol O. Potential role of dietary ω-3 fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum: a preliminary animal study on alternative therapeutic approach to schizophrenia. Prostaglandins Leukot. Essent. Fat. Acids. 69:2003;253-259
30. Saugstad L.F. Deviation in cerebral excitability: possible clinical implications. Int. J. Psychophysiol. 18:1994;205-212
31. Sogut S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozugurlu F., Sivasli E., Yetkin O., Yanik M., Tutkun H., Savas H.A., Tarakcioglu M., Akyol O. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin. Chim. Acta. 331:2003;111-117
32. Stevens J.R. Neuropathology of schizophrenia. Arch. Gen. Psychiatry. 39:1982;1131-1139
33. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34:1988;497-500
34. Takeuchi T., Fukumoto Y., Harada E. Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behav. Brain Res. 131:2002;193-203
35. Wainwright P.E., Xing H.C., Mutsaers L., McCutcheon D., Kyle D. Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6)/(n-3) ratio and very high levels of docosahexaenoic acid. J. Nutr. 127:1997;183
36. Wasowicz W., Neve S., Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin. Chem. 39:1993;2522-2526
37. Yao J.K., van Kammen D.P., Welker J.A. Red blood cell membrane dynamics in schizophrenia: II. Fatty acid composition. Schizophr. Res. 13:1994;217-226